These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 7513984)

  • 1. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
    Kim H; Yang XL; Rosada C; Hamilton SR; August JT
    Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent p53 gene mutations in serrated adenomas of the colorectum.
    Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
    J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
    Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas.
    Fujita M; Fukui H; Kusaka T; Morita K; Fujii S; Ueda Y; Chiba T; Sakamoto C; Kawamata H; Fujimori T
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1277-81. PubMed ID: 11129221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed analysis of genetic alterations in colorectal tumors from patients with and without familial adenomatous polyposis (FAP).
    Ichii S; Takeda S; Horii A; Nakatsuru S; Miyoshi Y; Emi M; Fujiwara Y; Koyama K; Furuyama J; Utsunomiya J
    Oncogene; 1993 Sep; 8(9):2399-405. PubMed ID: 8395678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
    De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
    Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
    van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
    Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis.
    Ward RL; Todd AV; Santiago F; O'Connor T; Hawkins NJ
    Cancer; 1997 Mar; 79(6):1106-13. PubMed ID: 9070487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoma-carcinoma sequence of colorectum. Prevalence of K-ras gene mutation in adenomas with increasing degree of dysplasia and aneuploidy.
    Ranaldi R; Gioacchini AM; Manzin A; Clementi M; Paolucci S; Bearzi I
    Diagn Mol Pathol; 1995 Sep; 4(3):198-202. PubMed ID: 7493139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
    Wielenga VJ; Heider KH; Offerhaus GJ; Adolf GR; van den Berg FM; Ponta H; Herrlich P; Pals ST
    Cancer Res; 1993 Oct; 53(20):4754-6. PubMed ID: 7691404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
    Kikuchi-Yanoshita R; Konishi M; Ito S; Seki M; Tanaka K; Maeda Y; Iino H; Fukayama M; Koike M; Mori T
    Cancer Res; 1992 Jul; 52(14):3965-71. PubMed ID: 1319835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma.
    Maesawa C; Tamura G; Suzuki Y; Ogasawara S; Sakata K; Kashiwaba M; Satodate R
    J Pathol; 1995 Jul; 176(3):249-58. PubMed ID: 7674088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
    Gallinger S; Vivona AA; Odze RD; Mitri A; O'Beirne CP; Berk TC; Bapat BV
    Oncogene; 1995 May; 10(9):1875-8. PubMed ID: 7753564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2).
    Schulenburg A; Cech P; Herbacek I; Marian B; Wrba F; Valent P; Ulrich-Pur H
    J Pathol; 2007 Oct; 213(2):152-60. PubMed ID: 17708598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic heterogeneity in sporadic colorectal adenomas.
    Saraga E; Bautista D; Dorta G; Chaubert P; Martin P; Sordat B; Protiva P; Blum A; Bosman F; Benhattar J
    J Pathol; 1997 Mar; 181(3):281-6. PubMed ID: 9155713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
    Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
    Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.